MIT Sloan BioInnovations Conference to Spotlight New Trends in Entrepreneurship, Financing, Personalized Medicine and Emer

MIT Sloan Healthcare Club and AVEO Pharmaceuticals kick off new Healthcare Case Competition

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- What type of healthcare financing and business models nurture entrepreneurship? Which novel approaches are enabling innovation? What does the future hold for personalized medicine? And how are global companies navigating diverse policies and regulations?

These questions and more will be addressed at this year’s MIT Sloan BioInnovations Conference: Driving Innovation & Entrepreneurship in a New Era. Now in its ninth year, the conference will be held on Friday, February 24, 2012 from 8am through pm at the Boston Marriott Cambridge located at Two Cambridge Center, 50 Broadway in Cambridge, MA. A poster session featuring MIT and other local university student research and networking session will follow. The 2011 conference attracted more than 250 participants from across the healthcare and life sciences industry, government, and academia.

Debuting this year is the MIT Sloan 2012 Healthcare Case Competition. Sponsored by the MIT Sloan Healthcare Club and AVEO Pharmaceuticals, the focus is on digital marketing for healthcare. A $4000 and $1600 cash prizes will be distributed to the first and second place teams.

Team Applications are due by 9pm February 9, 2012. For more information, please visit: http://sloanhcc.mit.edu/case-competition.html

Slated key note speakers for the conference are:

  • Chris Viehbacher, CEO of Sanofi;
  • Phillip Sharp, Nobel Laureate and co-founder of Biogen and Alnylam Pharmaceuticals Inc.; and
  • George Scangos, CEO of Biogen Idec.

Additional panel discussions will explore value network and open innovation business models in pharma; bringing value to limited partners and corporate investors; emerging market healthcare that tackles global challenges; and how personalized medicine is being used today.

“Our location in Kendall Square, which is one of the world’s leading biotechnology hubs, provides both MIT Sloan students and our conference attendees with key insights into the healthcare and life science industry,” says Conference Co-Chair Andrea Ippolito. “We are very excited about bringing together thought leaders from industry, academia, and government to facilitate healthy debate on current issues impacting two key healthcare growth drivers, that of innovation and entrepreneurship.”

Platinum sponsors for this year’s conference Philips Healthcare; Merck; and Sanofi.

For more information or to register for the conference, please visit: http://web.mit.edu/sloanhcc/bioinnovations/2012/index.html

The MIT Sloan Healthcare Club, formerly known as the Biomedical Business Club, leverages MIT’s unique cutting edge research, Boston’s biotech foundations, and leading area teaching hospitals to serve as a beacon for those in industry and academia through its annual BioInnovations Conference.



CONTACT:

For MIT Sloan
Paul Denning, 617-253-0576
Director of Media Relations
[email protected]
or
Patricia Favreau, 617-253-3492
Associate Director of Media Relations
[email protected]

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Education  University  Continuing  Other Education  Health  Biotechnology  Fitness & Nutrition  Professional Services  Banking  Finance  Research  Science  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.